OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Nov 20, 2015
Insider Transaction Report
Form 4
Danilkovitch Alla
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2015-11-19$5.08/sh+4,000$20,320→ 11,950 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2015-11-19$5.08/sh−4,000$20,320→ 89,000 totalExercise: $5.08From: 2013-03-23Exp: 2022-03-23→ Common Stock (4,000 underlying)